Back to search
FDAFDA · Food and drugs·Recall number D-608-2013

0.9% Sodium Chloride Injection, USP, 250 mL single dose Flexible Plastic Container, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-7983-02

Published June 26, 2013 · Recall initiated: June 6, 2013

Summary

FDA records drug Class II recall D-608-2013, published June 26, 2013 and initiated June 6, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 676,872 containers; Lot: Lot #: 16-031-JT*, Exp 1APR2014; Note the * may be followed by 01 or 02. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: The product has the potential for solution to leak at or near the administrative port of the primary container.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot #: 16-031-JT*, Exp 1APR2014; Note the * may be followed by 01 or 02
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.9% Sodium Chloride Injection, USP, 250 mL single dose Flexible Plastic Container, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-7983-02 recalled?

Yes. FDA published recall D-608-2013 on June 26, 2013. Reported hazard: Lack of Assurance of Sterility: The product has the potential for solution to leak at or near the administrative port of the primary container.

What should I do if I have this product?

Voluntary: Firm initiated · Letter